Related Experiment Video
Updated: Jul 2, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Reducing the delay in thrombolysis: is it necessary to await the results of renal function tests before computed
Manu Mehdiratta1, Gottfried Schlaug, Sandeep Kumar
1Stroke Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. mmehdira@bidmc.harvard.edu
Insights
Contrast agents are safe for most stroke patients. Only 8.4% of stroke patients were excluded due to renal function, and contrast-induced nephropathy occurred in only 3% of those receiving contrast.
Area of Science:
- Neurology
- Nephrology
- Radiology
Background:
- Code stroke protocols expedite evaluation and treatment for acute ischemic stroke.
- Computed tomography angiography (CTA) and computed tomography perfusion (CTP) are crucial for stroke assessment.
- Renal function is a key consideration for contrast agent administration in imaging.
Purpose of the Study:
- To determine the proportion of code stroke patients excluded from CTA/CTP due to renal function.
- To assess the incidence of contrast-induced nephropathy (CIN) in code stroke patients receiving contrast.
Main Methods:
- Retrospective analysis of a prospective code stroke database.
- Inclusion of 131 consecutive code stroke patients.
- Evaluation of emergency department laboratory results (creatinine, glomerular filtration rate).
Main Results:
- 8.4% of patients (11/131) would be excluded from contrast imaging based on creatinine > 1.5 mg/dL.
- 91% of excluded patients (10/11) had a known history of renal disease.
- 3% of patients who received contrast developed CIN.
Conclusions:
- Contrast administration in code stroke patients without known renal disease appears safe prior to definitive renal function tests.
- Pre-imaging renal function screening may exclude a small percentage of stroke patients.
- The incidence of CIN in this cohort is low, supporting judicious contrast use.
Objective:
We sought to determine the percentage of patients presenting with code stroke who would be excluded from computed tomography angiography, computed tomography perfusion, or both based on their emergency department laboratory results (creatinine and glomerular filtration rate) and the incidence of contrast-induced nephropathy in patients with code stroke who receive contrast.
Design:
We conducted a retrospective analysis of our prospective code stroke database.
Setting:
The study took place in an emergency department at a university medical center.
Results:
A total of 131 consecutive patients with code stroke were identified. Of these, 11 (8.4%) would not have received contrast based on a creatinine level greater than 1.5 mg/dL on initial evaluation. However, 10 of these 11 patients (91%) had a history of renal disease. A total of 3% of patients who received contrast developed contrast-induced nephropathy.
Conclusions:
Our findings suggest that the use of contrast agents in patients with code stroke before availability of renal function tests appears safe in patients who do not have a known history of renal disease.
Related Concept Videos
Imaging Studies VII: Vascular Imaging
Imaging Studies for Cardiovascular System V: CT
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies III: Computed Tomography
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies

